The United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in US manufacturing and nations with trade agreements are exempt. This move aims to boost domestic production. Generics are not affected. Indian companies exporting branded medicines to the US will need to assess the new rules.